Mars Inc. has acquired KIND North America. The two began their global partnership in 2017, when Mars bought a minority stake in the company in an agreement to grow KIND’s product offering and business globally.
KIND’s founder and executive chairman Daniel Lubetzky. Image courtesy of KIND.
Mars Inc. (McClean, VA) has acquired KIND North America (New York City, NY). The two began their global partnership in 2017, when Mars bought a minority stake in the company in an agreement to grow KIND’s product offering and business globally. The deal gave Mars the option to fully acquire KIND down the road, and now KIND North America will join KIND International to create one organization across 35 countries, functioning as a distinct and separate business within the Mars Family of Corporations. As part of the agreement, KIND’s founder and executive chairman Daniel Lubetzky will retain an ongoing financial stake, and play a key role in the company’s future developments and expansion.
“When we began this partnership, I said it was one built on mutual admiration and a shared vision for growth,” said Grant F. Reid, CEO of Mars, in a press release. “After three years, you can see the impact, as together we have grown the healthy snacking category and brought KIND and the KIND Promise to 35 countries and into new categories. We’re delighted to continue to build on this success and welcome KIND North America into the Mars Family of Companies.”
“I am so proud of how well the Mars and KIND teams have complemented and strengthened each other over the past three years,” Lubetzky said in a press release. “We are now well positioned to further advance our efforts and continue building a foremost health and wellness platform. As we said in 2017, Mars is a company that shares KIND’s passion for business as a force for good, and I am confident that together, we will be able to make our small contribution to make this world a little kinder."
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.